Article (Scientific journals)
Methodological validation of Miro1 retention as a candidate Parkinson's disease biomarker.
Drwesh, Layla; ARENA, Giuseppe; Merk, Daniel J et al.
2025In NPJ Parkinson's Disease, 11 (1), p. 270
Peer Reviewed verified by ORBi
 

Files


Full Text
s41531-025-01115-8.pdf
Publisher postprint (2.18 MB) Creative Commons License - Public Domain Dedication
Download

All documents in ORBilu are protected by a user license.

Send to



Details



Keywords :
MIRO1; Parkinson's disease; iPSC; Mitochondria
Abstract :
[en] Mitochondrial markers help stratify Parkinson's disease (PD) patients. We use high-throughput blotting to quantify Miro1, Mfn2, and VDAC levels in fibroblasts, blood cells, and iPSC-derived neurons. Miro1 is specifically retained in PD cells but degraded in healthy ones after mitochondrial depolarization. We correlate Miro1 retention scores with pathogenic mutations, genetic background, age, and clinical data. This scalable assay and quantifiable score for mitochondrial-PD support biomarker development and pharmacological screening.
Research center :
Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group)
Luxembourg Centre for Systems Biomedicine (LCSB): Clinical & Experimental Neuroscience (Krüger Group)
Luxembourg Centre for Systems Biomedicine (LCSB): Molecular & Functional Neurobiology (Grünewald Group)
Disciplines :
Genetics & genetic processes
Neurology
Author, co-author :
Drwesh, Layla;  Department of Neurodegeneration, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany
ARENA, Giuseppe  ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine > Translational Neuroscience > Team Rejko KRÜGER
Merk, Daniel J;  Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany
FERRANTE, Daniele ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine > Translational Neuroscience > Team Rejko KRÜGER
GORGOGIETAS, Vyron ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Translational Neuroscience
Gasser, Thomas;  Department of Neurodegeneration, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany ; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
GRÜNEWALD, Anne  ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Molecular and Functional Neurobiology
MAY, Patrick  ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Bioinformatics Core
Brockmann, Kathrin;  Department of Neurodegeneration, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany ; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
KRÜGER, Rejko ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Translational Neuroscience ; Centre Hospitalier de Luxembourg > Parkinson Research Clinic ; Transversal Translational Medicine > Luxembourg Institute of Health (LIH), Strassen
Wüst, Richard;  University Hospital Tübingen, Center for Mental Health, Eberhard Karls University Tübingen, Tübingen, Germany
Gloeckner, Christian Johannes;  German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
Fitzgerald, Julia C;  Department of Neurodegeneration, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany. julia.fitzgerald@uni-tuebingen.de
More authors (3 more) Less
External co-authors :
yes
Language :
English
Title :
Methodological validation of Miro1 retention as a candidate Parkinson's disease biomarker.
Publication date :
15 September 2025
Journal title :
NPJ Parkinson's Disease
eISSN :
2373-8057
Publisher :
Nature Publishing Group, New-York, Us ny
Volume :
11
Issue :
1
Pages :
270
Peer reviewed :
Peer Reviewed verified by ORBi
Focus Area :
Systems Biomedicine
Development Goals :
3. Good health and well-being
Funders :
MJFF - Michael J. Fox Foundation for Parkinson's Research
Funding number :
MJFF (021967)
Available on ORBilu :
since 16 September 2025

Statistics


Number of views
48 (2 by Unilu)
Number of downloads
14 (0 by Unilu)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenCitations
 
0
OpenAlex citations
 
1

Bibliography


Similar publications



Contact ORBilu